Michael Peery, MD
Otolaryngology · Corinth, MSNPI 1730295064
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $754 of the $945 with a category attached, or 79.8%. Medical Device Business Services, Inc. accounts for 79.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $828 and has fallen 98.2% since, to $15 in 2023. That places this record below the midpoint for otolaryngology clinicians in MS, where the typical reported total is $1,327.
Across 14 payments — averaging $67.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$754
- Intersect ENT, Inc.$83
- Medtronic$35
- Acclarent, Inc$35
- Boston Scientific$13
- Pentax Of America, Inc.$12
- plus $12 from 1 others
What the payments were for
- Travel & lodging$75480%
- Food & beverage$19020%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 1 | $754 |
| Intersect ENT, Inc. | 6 | $83 |
| Medtronic | 2 | $35 |
| Acclarent, Inc | 2 | $35 |
| Boston Scientific | 1 | $13 |
| Pentax Of America, Inc. | 1 | $12 |
| Smith+Nephew | 1 | $12 |
How this compares
$945 in reported general payments places this provider in the 40th percentile of 97 otolaryngology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 122 | $3,569 |
| Montelukast Sodium | 219 | $1,464 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 16 | $723 |
| Fluticasone Propionate | 62 | $645 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $339 |
| Pilocarpine Hcl | 12 | $333 |
| Famotidine | 29 | $210 |
| Methylprednisolone | 33 | $201 |
| Pantoprazole Sodium | 13 | $127 |
| Omeprazole | 16 | $123 |
| Diazepam | 12 | $56 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $39 |
| Meloxicam | 13 | $29 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Corinth
- Raymond WeissOcean Springs$258K
- Robert YarberTupelo$7K
- Charles WilsonOcean Springs$7K
- Gregory PippinMcComb$6K
- Savannah StocktonBrookhaven$6K
- John SchweinfurthJackson$6K
- Jess RobertsJackson$5K
- Byron WindhamOxford$5K
- Thomas EbyJackson$5K
- Anne KaneJackson$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.